Oncology
Oncology trials demand rigor, speed, and deep empathy for patients facing life-altering diagnoses. At UNIQ, we combine scientific excellence with agile, well-controlled operations to support the development of breakthrough cancer therapies—without compromising quality or compassion.
Oncology
Oncology trials demand rigor, speed, and deep empathy for patients facing life-altering diagnoses. At UNIQ, we combine scientific excellence with agile, well-controlled operations to support the development of breakthrough cancer therapies—without compromising quality or compassion.
Our Purpose in Oncology
Oncology is where unIQ’s story began — a field that demands both scientific rigor and human empathy. Over the past decade, our teams have supported transformative oncology programs, from first-in-human immunotherapies to large, global Phase III trials.
Every cancer study is personal — a balance of precision, urgency, and care. Our mission is to make every protocol an intelligent, human-centered pursuit of better outcomes.
Core Oncology Expertise
Humanizing Oncology
Where precision meets compassion.
Beyond numbers are lives. From simplified consent to multilingual support and flexible tele-visit options, we remove barriers so patients can focus on healing — not paperwork.
Every participant becomes a true partner in science, and our study designs honor their dignity, comfort, and safety at every step.
Oncology studies are uniquely demanding — emotionally, medically, and logistically.
Data-Powered Precision
Our oncology delivery platform combines AI-driven feasibility, predictive site activation, and transparent real-time dashboards.
With intelligent analytics, sponsors achieve faster enrollment and cleaner data integrity.
Countries
Oncology Studies
Global Sites
What Sets Our Oncology Approach Apart
Patient-Centered Experience
- Simplified consent and easy-to-understand materials
- Multi-language support for global accessibility
- Tele-visits, eConsent & remote symptom tracking
Smarter Enrollment & Site Strategy
- Predictive enrollment based on tumor type & country performance
- Oncology-experienced global sites
- Streamlined pre-screening to reduce screen fails
Stronger Safety & Data Oversight
- Real-time monitoring of AEs/SAEs, labs, imaging
- Machine-assisted detection of risks and deviations
- Faster medical review for cleaner interim analyses